SKB315 is a novel CLDN18.2-directed ADC for advanced solid tumors, configured with a proprietary, in-house developed humanized CLDN18.2 mAb and a differentiated payload-linker design. Building upon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback